CANY
CLOV icon

Caxton Associates (New York)’s Clover Health Investments CLOV Stock Holding History

Caxton Associates (New York)’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$392K Buy
124,460
+112,656
+954% +$403K 0.01% 373
2024
Q3 		$33.3K Buy
+11,804
New +$27K ﹤0.01% 512

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Caxton Associates (New York)'s CLOV Position: Q4 2024 in Review

Caxton Associates (New York) increased its Clover Health Investments (CLOV) stake by 954% in Q4 2024, buying an estimated $403K and bringing the position to 124,460 shares worth $392K. The position accounts for 0.01% of the portfolio, ranked #373.

Caxton Associates (New York) first reported a position in CLOV in Q3 2024 and has held it in 2 quarters since. 178 funds tracked by Wall St. Rank hold CLOV as of Q4 2024.

  • Caxton Associates (New York) held 124,460 shares of Clover Health Investments worth $392K as of Q4 2024.
  • Caxton Associates (New York) bought 112,656 Clover Health Investments shares in Q4 2024, an estimated $403K.
  • Clover Health Investments made up 0.01% of Caxton Associates (New York)'s portfolio in Q4 2024, its #373 holding.
  • Caxton Associates (New York) first reported a position in Clover Health Investments in Q3 2024 and has held it in 2 quarters since.
  • 178 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.